Back to HSBC Holdings plc HSBC Holdings plc

XERSXERS

Showing 6 of 17 quarters

Position history for HSBC Holdings plcHSBC Holdings plc's holdings in Xeris Biopharma Holdings, Inc.

Yes. HSBC Holdings holds 41,779 shares of XERS, worth $329,636, as of its Q2 2026 13F filing. It increased the position by 10,604 shares (+34.0%) from Q1 2026. HSBC Holdings has held XERS since Q1 2026, across 2 quarterly 13F filings.

Current Value

$329,636

Current Shares

41,779

Total Value Change

+$262,320

Total Shares Change

+18,118

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
41,779
+34.0%
$329,6360.0%$7.92
30
2026-Q1
New
31,175
—
$182,6860.0%—
31
2025-Q2
Exited
0
-100.0%
$00.0%—
0
2025-Q1
Decreased
16,205
-0.7%
$87,9930.0%—
0
2024-Q4
Decreased
16,312
-31.1%
$55,5420.0%—
0
2024-Q3
Decreased
23,661
-1.3%
$67,3160.0%$2.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used